logo

NHTC

Natural Health Trends·NASDAQ
--
--(--)
--
--(--)
1.20 / 10
Underperform

NHTC's fundamental health is subpar (1.2/10). Key weaknesses include negative returns on assets (-0.6024) and net profit margins (-0.9791), while only the Quick ratio (2.4218) offers a modest positive signal. Historical back-tests indicate negative monthly returns for most factors, reinforcing the need for caution on the fundamental side.

Fundamental(1.2)SentimentTechnical

Analysis Checks(2/10)

ROA (%)
Value-0.60
Score1/3
Weight7.44%
1M Return-4.34%
Net assets per share (growth rate compared to beginning of year %)
Value-20.46
Score0/3
Weight16.38%
1M Return-7.88%
Net cash flow from operating activities / Operating revenue (%)
Value-16.78
Score2/3
Weight4.13%
1M Return-1.80%
Quick ratio
Value2.42
Score3/3
Weight-2.58%
1M Return0.95%
Profit-MV
Value0.47
Score1/3
Weight11.87%
1M Return-5.91%
Net profit margin (%)
Value-0.98
Score1/3
Weight9.52%
1M Return-4.05%
Annualized net profit margin on total assets (%)
Value-0.80
Score1/3
Weight7.44%
1M Return-4.34%
Net profit / Total operating revenue (%)
Value-0.98
Score1/3
Weight9.52%
1M Return-4.05%
Asset-MV
Value-0.51
Score1/3
Weight20.28%
1M Return-16.15%
Cash-MV
Value-3.19
Score1/3
Weight16.00%
1M Return-11.95%
Is NHTC undervalued or overvalued?
  • NHTC scores 1.20/10 on fundamentals and holds a Premium valuation at present. Backed by its -1.00% ROE, -0.29% net margin, 126.71 P/E ratio, 1.69 P/B ratio, and -116.67% earnings growth, these metrics solidify its Underperform investment rating.